OBJECTIVES: Bronchopleural fistula (BPF) is an uncommon complication following a lung resection to address various conditions. BPFs are associated with high morbidity and mortality rates. This study evaluated the endoscopic treatment of 'total' BPFs using the Occlutech-F ıgullaV R cardiac device at a single centre.
INTRODUCTION
Bronchopleural fistulas (BPFs) usually result from lung resections performed under different conditions. The incidence of BPF varies from 0 to 28%, and the mortality rate varies from 16% to 72% [1] [2] [3] . BPFs are more frequent in pneumonectomy cases than in lobectomy cases. However, the literature does not indicate the percentage of fistulas that arise from partial or total bronchial stump dehiscence [2] . Several factors are associated with the occurrence of BPFs, including insulin-dependent diabetes [4] , neoadjuvant radiotherapy [5] , residual tumour at the stump [1] , lung abscess [6] , bronchiectasis [7] , tuberculosis [8, 9] , malnourishment [10] , immunosuppression [11] and steroid use [12] . Moreover, technical intraoperative aspects, such as extensive dissection, suture type and the need for prolonged mechanical ventilation, can contribute to the onset of dehiscence.
Bronchial stump fistulas should be surgically treated; however, patients in poor clinical conditions or those with high anaesthetic and surgical risk might not be feasible surgical candidates. In addition, large diameter fistulas, such as those resulting from complete stump dehiscence ('total' fistulas), and fistulas with a significant air leak might worsen the severity of the clinical condition by impairing the patient's ventilation, even leading to speech impairment.
Less invasive approaches have been used to treat BPFs, such as bronchoscopic treatments using different fibrin sealants [13] , coils [14] , covered stents [15, 16] and unidirectional valves [17] , as well as the induction of local inflammation through the submucosal injection of substances such as silver nitrate [18] or polidocanol [19] . Satisfactory outcomes have been demonstrated only for cases with a 'partial' fistula of up to 8 mm, in which the bronchial stump dehiscence was incomplete.
In cases of 'total' fistulas, it is almost impossible to maintain the occluding material in place. Thus, endoscopic treatment is not effective for this type of fistula.
Recently, a favourable outcome with closure of two 'partial' fistulas (5 mm in diameter) was described that used a device involved in the percutaneous treatment of interatrial defects [20, 21] . We hypothesized that a similar occluder, the OcclutechFigulla ASD V R device (Occlutech AB, Helsingborg, Sweden), might be an interesting alternative for the bronchoscopic treatment of high-risk patients with 'total' fistulas; this alternative has not been previously performed. The advantageous features of the Occlutech-Figulla device are its thinner and numerous braided Nitinol threads; this flexible braiding could enable the implant to adapt to the shape of the fistula and effectively close it. Moreover, a polyethylene patch is located inside each of the discs to support immediate closure. Another important advantage of the device's profile is the absence of a left-sided hub, which could minimize the risk of damaging adjacent mediastinal structures during implantation.
This study describes a single centre's experience with a new method of endoscopic treatment of patients with 'total' chronic bronchial stump dehiscence; this method uses the OcclutechFigulla ASD V R device, which was originally designed for the percutaneous treatment of atrial septal defects.
MATERIALS AND METHODS
The prospective study protocol was approved by the Institute's Ethical Committee (CAPPesq number 1089/09) and was registered at ClinicalTrials.gov (Identifier: NCT01153074). The study population included all consecutive patients with BPFs referred to the Thoracic Department of our institution between June 2010 and June 2014. The only exception was Patient #3, who was originally operated in our Service. Three cases were not included in the study because they did not have total fistulas, i.e. stump dehiscence was partial. Written informed consent was obtained from each participant. Nine patients were enrolled in this study, including seven men (mean age = 45 ± 11.1 years; range, 30-72 years) who had been diagnosed with 'total' chronic bronchial stump dehiscence on bronchoscopy. All patients had a prohibitively high anaesthetic or surgical risk or refused to be operated again. According to the inclusion criteria, the patients did not have signs of acute inflammation or active disease in the stump, and the pleural cavity was cleared after adequate drainage via a chest tube or a thoracostomy.
All of the patients exhibited dyspnoea upon mild exertion. Eight patients had impaired phonation caused by air leakage through the fistula. The demographic characteristics, degree of dyspnoea and speech disorders of the sample are described in Table 1 .
The underlying diseases leading to lung dissection were tuberculosis sequelae in six patients (66.7%), lung neoplasms in two patients (22.2%) and necrotizing pneumonia in one patient who was immunosuppressed after kidney transplantation (11.1%). Most of the resections associated with fistulas were performed on the right lung (six cases, 66.7%). The fistula diameter varied from 6 to 17 mm (15.0 ± 3.65 mm). In two patients, the fistula diameter was <8 mm (Patient #2: 7 mm; Patient #8: 6 mm), and both resulted from total bronchial stump dehiscence. One BPF resulted from a left lower lobectomy after Patient #2 had a left upper lobectomy. This patient developed total dehiscence in both bronchial stumps. Patient #8 had a BFP after a right upper lobectomy due to necrotizing pneumonia during the postoperative course of kidney transplantation. Table 2 shows the underlying disease presented by the patients, the surgery performed, the BPF localization, the homolateral pleural space treatment, the time when the patients presented the fistula and the number of previous surgical or bronchoscopic fistula closure attempts.
The median duration of the fistulas was 5.93 years (range, 0.25-17 years), and (except for Patients #4 and #5) all patients had undergone previous surgical or bronchoscopic fistula closure attempts.
Procedure
All of the patients underwent pulmonary inhalation scintigraphy to determine the air leakage pattern at baseline. Bronchoscopy and device implantation were performed in the operating room under sedation via intravenous midazolam (5-7 mg) and fentanyl (50 mg) and the topic endobronchial anaesthesia approach. The patients were maintained under spontaneous ventilation with supplemental oxygen via a nasal cannula. The fistula diameter was estimated by filling an Arndt Endobronchial Blocker Set (Cook Medical, Bloomington, IN, USA) catheter with saline solution until the balloon wall touched the full circumference of the fistulous tract. The catheter was then removed, the balloon was filled again with the same volume of saline solution, and the diameter was precisely measured using a calliper. The size of the Occlutech-Figulla ASD V R occluder was determined by the diameter of its waist, which is the intermediate portion between the discs, and this point effectively exerts the radial fixation force ( Fig. 1 ). The diameter of the waist of the devices used in this study was 20-30% larger than the diameter of the fistulas; this ratio is considered safe for use in interventional cardiology. The diameter of the device waist varied from 9 to 24 mm (mean = 15 ± 4.48 mm).
A catheter, through which we advanced the delivery sheath and the device, was inserted into the fistulous tract with a guide wire. First, the distal disc was released into the pleural cavity. Then, the central waist was extruded inside the fistula, and the proximal disc was fit inside the bronchial stump, taking care not to occlude bronchi from the remnant segments (Fig. 2) . In patients with previous thoracostomies or chest tubes >32 French, the release of the distal disc into the pleural cavity was observed through a rigid optic fibre, thus avoiding the necessity of radioscopy to guide the release of the occluder distal disc in the pleural cavity (Fig. 3) .
Follow-up assessment
The following parameters were assessed over 12 months: complete blood count, C-reactive protein, bronchoalveolar lavage and periprosthetic tissue biopsy. Infectious events and local complications such as device displacement, bleeding and injury of adjacent structures were also monitored. All of the patients received control bronchoscopies on the 7th and 14th postoperative days, as well as 1, 2, 4, 6 and 12 months after device implant. At the end of the follow-up period, the participants had a clinical interview, a bronchoscopy with methylene blue staining and pulmonary inhalation scintigraphy to assess the bronchial stump closure outcomes (Fig. 4) .
The complete occlusion of the fistula, confirmed via bronchoscopic evaluation, a negative methylene blue test, a significant decrease in reporting of symptoms with the device well positioned on the stump (or some combination therein), was considered a favourable outcome. 
Statistics
The results are reported as the means ± standard deviations for data with a normal distribution (Shapiro-Wilk test) and as medians (with ranges) for data with a non-normal distribution (IQ 25-75% ). A repeated-measures analysis of variance was used to compare data with a normal distribution. A Friedman test was used to compare data with a non-normal distribution. A P-value of <0.05 was considered as significant.
RESULTS
Five patients remained with the occluder in place. Closure in the fistula tract was complete in three patients (Patients #1, #6 and #8) who developed unremarkable postoperative courses. The fistulas became occluded following granulation tissue formation, with a consequent disappearance of air leakage, clinical improvement, negative bronchoscopy and methylene blue stain test results. Partial closure occurred in two patients (#3 and #9). Although pulmonary inhalation scintigraphy demonstrated residual air leaks in those two cases, air leakage from the chest drain and respiratory work were significantly reduced. Improvement in clinical status and weight gain resulted, thereby reducing the surgical risk of those patients. Patient #2, who presented with two fistulas and developed no local tissue reaction, had the device removed at the end of the protocol. Patient #4 developed device displacement at the sixth-month follow-up assessment. During repositioning, some of the Nitinol threads of the proximal disc were broken. The occluder was then removed to avoid the risk of lesion on the adjacent structures. Patients #5 and #7 died during the follow-up period due to causes unrelated to the procedure or device. Table 3 shows the data regarding fistula size, device used and outcomes.
Bronchoalveolar lavage
All cultures collected from Patient #2 contained Pseudomonas aeruginosa and showed the same sensitivity profile, which was considered as colonization. The samples collected from the other patients were negative for bacterial growth.
Bronchoscopic biopsy
None of the periprosthetic tissue samples exhibited signs of local infection, only repair tissue (44.4%) and unspecific chronic inflammatory process (55.6%).
Infectious events
No signs of infection were associated with the device. Neither the white cell count (P = 0.412) nor the C-reactive protein level (P = 0.318) exhibited significant variation indicative of related infection.
Stump bronchoscopic evaluation
The stump assessment via bronchoscopy confirmed that the device was in the appropriate position in five patients, although displacement occurred in two patients. Except for one case of early death and another case without a local reaction, granulation tissue formation adjacent to the prosthesis was confirmed in all patients. A bronchoscopy also detected the rupture of the metallic wires at their junction point on the proximal disc in one patient who was one of two who required device removal.
Methylene blue stain test
Dye extravasations into the pleural cavity were performed for the two patients who required removal of the device. The dye was not retrieved from the pleural cavities of the three patients with complete occlusion or from the two patients with apparent total occlusion on bronchoscopy and leakage detected only on scintigraphy.
Inhalation scintigraphy
Scintigraphy was performed using a dual-headed SPECT scintillation camera (E-cam V R , Siemens, Hoffman Estates, IL, USA). Inhalation was performed with 900-1300 MBq (25-35 mCi) of diethylenetriaminepentaacetic acid labelled with technetium99m inserted into a nebulizer. The estimated activity that reached and was retained in the lungs was 20-40 MBq (0.5-1.0 mCi). Significant radionuclide leaks into the pleural cavity were detected on all of the preintervention lung scintigraphy scans. Among the patients who required device removal, the leakage pattern on scintigraphy did not change relative to the baseline values. On follow-up, scintigraphy was negative for leakage among the three patients with complete closure. Pulmonary inhalation scintigraphy demonstrated the residual leakage of radionuclides in the two patients (#3 and #9) for whom the other tests failed to detect the presence of a fistula.
Local complications
Device displacement in the bronchial stump occurred in two patients. We chose to remove the device from one patient (#4) because of a simultaneous fracture of the metallic wires. For the other patient (#3), a conservative approach was adopted that resulted in granulation tissue formation and the occlusion of the bronchial stump, as confirmed by bronchoscopy.
DISCUSSION
The current report describes the experiences of a single centre using the cardiac device Occlutech-Figulla4295
V R for the endobronchial treatment of 'total' bronchial stump fistulas. Patients presenting with such critical complications are usually in poor In this study, the largest prevalence of fistulas was associated with resections resulting from infectious lung diseases such as tuberculosis and fungal infections that are common in underdeveloped and developing countries [22] .
Bronchopleural fistula occlude
As a result of a previous experience involving the endoscopic treatment of fistulas [23] [24] [25] , we began using the atrial septal occluder device in 2009 to manage a large BPF that developed after a right upper lobectomy in a patient with tuberculosis [26] . We chose the Occlutech-Figulla ASD V R device based on the assumption that its design, which includes two discs (one released into the pleural cavity and the other into the bronchial stump), together with the radial force exerted by its waist on the fistulous tract, might reduce the risk of displacement. In addition, the device's metallic mesh serves as a matrix for granulation tissue formation, which might also contribute to fistula closure. We believe that this device provides better adaption during implantation because of its flexible braiding, thereby minimizing potentially fatal complications such those due to respiratory movements. Moreover, its design also permits clinicians to monitor any rupture of the braided nitinol threads during a follow-up bronchoscopy.
Because part of the device fixation is caused by the radial force exerted by the waist against the bronchial wall, the measurement of the bronchial stump diameter is crucial to select the appropriate device. Radiological methods, such as chest tomography, only provide static measurements that do not take bronchial wall compliance into account and therefore might underestimate the fistula diameter. For this reason, we used the balloon of the bronchial blocker catheter under bronchoscopic visualization to estimate the bronchial stump diameter with greater precision.
Clinical outcome
The predominance of male patients and right lung fistulas is consistent with the data in the international literature; however, no reports have described the endoscopic treatment of 'total' bronchial stump fistulas.
Because the device was designed for intracardiac use, a concern existed that when it was placed in the airways (i.e. in contact with the external environment through respiration or the open pleural cavity), it might be a source of infection. However, the close monitoring of infectious complications did not demonstrate significant abnormalities in the white cell count or C-reactive protein level. The surveillance endoscopic biopsies of periprosthetic tissue indicated repair tissue only, with no signs of disease reactivation or the presence of new infectious agents.
The mechanical effect of the device implant into the bronchial stump, which led to the accentuated reduction of the air leakage through the fistula and the improvement of patients' respiratory patterns and phonation capacities, is important to emphasize. In addition, pleural secretion progressively decreased.
According to the bronchoalveolar cultures from the remnant lung parenchyma, Pseudomonas aeruginosa was detected in only one patient who showed the same profile of antibiotic sensitivity without clinical or laboratory manifestations of infection; therefore, its presence was considered as colonization. Bacterial growth was not detected in any of the samples collected from the remaining patients.
Bronchoscopy was paramount during patient follow-up because it enabled sample collection for infection surveillance, the assessment of the device position, and granulation tissue formation and the monitoring of the occurrence of local complications.
Pulmonary inhalation scintigraphy was useful for detecting BPF in two patients who were not confirmed by bronchoscopy at the 12-month follow-up assessment, which was considered the gold standard for the purpose of comparison. Subsequently, those patients developed persistent air leakage, thereby confirming the scintigraphy findings. We believe that this technique is more sensitive and has higher accuracy for indicating the presence of fistula. The pulmonary inhalation scintigraphy technique is described in detail elsewhere [27] .
Our results suggest that in patients who are unable to sustain surgical correction, the endoscopic treatment of fistulas should be considered, even if the fistulas resulted from complete dehiscence of a bronchial stump. Moreover, this technique can be used without radioscopy and general anaesthesia, without infection complications and without mediastinal structure injuries by the occlude, which reinforces our impression. Nevertheless, one of the limitations of this study is that it was small, which does not enable us to formulate definitive conclusions. Future studies should assess the safety and efficacy of the investigated method in a large series.
